(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 5.56% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Abbott Laboratories's revenue in 2024 is $40,326,000,000.On average, 6 Wall Street analysts forecast ABT's revenue for 2024 to be $72,465,587,170,525, with the lowest ABT revenue forecast at $72,362,153,766,116, and the highest ABT revenue forecast at $72,618,408,777,352. On average, 6 Wall Street analysts forecast ABT's revenue for 2025 to be $77,461,844,900,147, with the lowest ABT revenue forecast at $77,124,383,785,041, and the highest ABT revenue forecast at $77,772,762,683,358.
In 2026, ABT is forecast to generate $82,536,466,172,076 in revenue, with the lowest revenue forecast at $81,876,854,458,578 and the highest revenue forecast at $83,111,002,836,225.